1. Xu J, Kochanek KD, Murphy SL, Tejada-Vera B. Deaths: Final Data for 2007. National Vital Statistics Reports. Vol 58. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2010.
2. Raab SS, Grzybicki DM. Quality in Cancer Diagnosis. CA Cancer J Clin. 2010;60(3):139-165.
3. Kim M, Kim E-K, Lee J, et al. Breast lesions with imaging-histologic discordance during US-guided 14G automated core biopsy: can the directional vacuum-assisted removal replace the surgical excision? Initial findings. Eur Radiol. 2007;17(9):2376-2383.
4. Altekruse SF, Kosary CL, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2007. Bethesda, MD: National Cancer Institute; 2010.
5. American College of Radiology. About US. 2010; http://www.acr.org/MainMenuCategories/about_us.aspx. Accessed August, 20, 2010.
6. College of American Pathologists. CAP Facts. 2010; http://www.cap.org/apps/cap.portal?_nfpb=true&cntvwrPtlt_actionOverride=%2Fportlets%2FcontentViewer%2Fshow&_windowLabel=cntvwrPtlt&cntvwrPtlt%7BactionForm.contentReference%7D=media_resources%2Fcollege_facts.html&_state=maximized&_pageLabel=cntvwr. Accessed August 20, 2010.
7. Buchbinder SS, Leichter IS, Lederman RB, et al. Can the size of microcalcifications predict malignancy of clusters at mammography? Acad Radiol. 2002;9(1):18-25.
8. Youk JH, Kim E-K, Kim MJ, Lee JY, Oh KK. Missed Breast Cancers at US-guided Core Needle Biopsy: How to Reduce Them. Radiographics. January 2007 2007;27(1):79-94.
9. IMV. 2008 Mammography Benchmark Report. Des Plaines, IL: IMV;2008.
10. Liberman L, Gougoutas CA, Zakowski MF, et al. Calcifications Highly Suggestive of Malignancy: Comparison of Breast Biopsy Methods. Am. J. Roentgenol. July 1, 2001 2001;177(1):165-172.
11. Liberman L, Drotman M, Morris EA, et al. Imaging-histologic discordance at percutaneous breast biopsy. Cancer. 2000;89(12):2538-2546.
12. Liberman L. US-guided core breast biopsy: use and cost effectiveness. Radiology. 1998;208(3):717-723.
13. U.S. Food and Drug Administration. Mammography Quality Standards Act (MQSA). 2010; http://www.fda.gov/Radiation-EmittingProducts/MammographyQualityStandardsActandProgram/Regulations/ucm110823.htm. Accessed August 19, 2010.
14. Lee J-M, Kaplan JB, Murray MP, et al. Imaging Histologic Discordance at MRI-Guided 9-Gauge Vacuum-Assisted Breast Biopsy. Am. J. Roentgenol. October 1, 2007 2007;189(4):852-859.
15. Mihalik JE, Krupka L, Davenport R, Tucker L, Toevs C, Smith RS. The rate of imaging-histologic discordance of benign breast disease: a multidisciplinary approach to the management of discordance at a large university-based hospital. Am J Surg. 2010;199(3):319-323.
16. American Cancer Society. Cancer Facts & Figures 2010. Atlanta, GA: American Cancer Society, Inc.;2010.
17. Youk J, Kim E-K, Kim M, Kwak J, Son E. Analysis of false-negative results after US-guided 14-gauge core needle breast biopsy. Eur Radiol. 2010;20(4):782-789.
18. Kim M, Kim E, Park S, et al. Imaging-histologic discordance at sonographically guided percutaneous biopsy of breast lesions. Eur J Radiol. 2008;65(1):163-169.
19. The Altarum Institute. Electronic Reporting in Pathology: Requirements and Limitations. Washington, DC: Office of Assistant Secretary of Planning and Evaluation, U.S. Department of Health and Human Services 2009.
20. Radiological Society of North America. RSNA Informatics: RadLex. 2010; http://www.rsna.org/informatics/radlex.cfm. Accessed May 20, 2010.
21. Langlotz CP. RadLex: A New Method for Indexing Online Educational Materials. Radiographics. 2006;26(6):1595-1597.
22. Radiological Society of North America. RSNA Informatics: Reporting. 2010; http://www.rsna.org/informatics/radreports.cfm. Accessed May 20, 2010.
23. Menck H. Types and Charactersitics of Central Registries, Ch 1 In: Hutchison C, Menck H, Burch M, Gottschalk R, eds. Cancer Registry Management: Principles and Practice. Second ed. Dubuque, IA: Kendall Hunt Publishing Co.; 2004.
24. Schneider A. Progress in Cancer Control through Cancer Registries. CA Cancer J Clin. 1958;8:207-210.
25. American Cancer Society. The Hospital Cancer Registry: Definition, Purpose, Value, Operation and Cost. New York, NY: American Cancer Society, Inc.;1966.
26. IntleKofer R, Michaud F. The National Program of Cancer Registries, Chapter 29 In: Menck H, Deapen D, Phillips J, Tucker T, eds. Central Cancer Registries: Design, Management and Use. Second ed. Dubuque, IA: Kendall Hunt Publishing Co.; 2007.
27. North American Association of Central Cancer Registries. Standards for Cancer Registries, Volume V, Pathology Laboratory Electronic Reporting, Version 2.0. Springfield, IL: North American Association of Central Cancer Registries Inc.;2006.
28. North American Association of Central Cancer Registries. Electronic Pathology (E-Path) Reporting Guidelines. 2006; http://old.naaccr.org/filesystem/pdf/E-Path%20Reporting%20Guidelines_FINAL_01-29-07%20.pdf. Accessed May 31, 2010.
29. North American Association of Central Cancer Registries. Standards for Cancer Registries, Volume II, Data Standards and Data Dictionary, Fifteenth Edition, Version 12.1. Springfield, IL: North American Association of Central Cancer Registries;2010.
30. U.S. Department of Health and Human Services. Report on the Reporting Pathology Protocols for Colon and Rectum Cancers Project. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion;2005.
31. American College of Pathologists. Diagnostic Intelligence & Health Information Technology (DIHT) June 2009 Survey;2009.
32. National Electrical Manufacturers Association. Digital Imaging and Communications in Medicine (DICOM) Supplement 145: Whole Slide Microscopic Image IOD and SOP Classes. 2010; ftp://medical.nema.org/medical/dicom/2009/. Accessed October 4, 2010.
33. American College of Radiology. ACR Launches American Institute for Radiologic Pathology. 2010; http://www.acr.org/HomePageCategories/News/ACRNewsCenter/ACRLaunchesAIRP.aspx. Accessed July, 21, 2010.